MedTrace Logo

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity

NCT02069132 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 376

Last updated 2017-04-27

No results posted yet for this study

Summary

The purpose of this study is to validate the International Warfarin Pharmacogenetics Consortium (IWPC) algorithm in a prospective cohort of elderly people (65 years or older) with heart valves and/or nonvalvular atrial fibrillation (AF) and at least one comorbid condition, and to assess the algorithm's prognostic relevance.

Conditions

Interventions

DRUG

Warfarin

warfarin treatment will be determined by treating physicians according to in-hospital guidelines, blindly to genotype assessment.

Sponsors & Collaborators

  • Federico II University

    collaborator OTHER

  • University of Salerno

    collaborator OTHER

  • University of Campania Luigi Vanvitelli

    lead OTHER

Principal Investigators

  • Ciro Gallo, MD · University of Campania Luigi Vanvitelli

  • Amelia Filippelli, MD · University of Salerno

  • Marisa De Feo, MD · University of Campania Luigi Vanvitelli

  • Nicola Ferrara, MD · Federico II University

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2017-12-31
Completion
2018-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02069132 on ClinicalTrials.gov